Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0000899243-22-007423

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SQUINTO STEPHEN P Director 2022-02-18 Grant or award · Stock Option (Right to Buy) +30,000 30,000 D
Loading xslF345X03/doc4.xml…